China Resources Sanjiu Medical & Pharmaceutical Co Ltd
000999.SZ · Health Technology · Pharmaceuticals: Major · CN
15,599 employees · 999.com.cn
About
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. generates revenue through the manufacture, development, and sale of pharmaceutical products, including over the counter drugs and prescription drugs. These products address treatment needs in cold, gastroenterology, dermatology, pediatrics, cardiovascular and cerebrovascular diseases, anti-tumor, anti-infection, digestive system, and orthopedics areas. The company also earns income from its packaging and printing and international trading businesses, distributing its offerings in the domestic market and to overseas markets. The firm operates from its headquarters in Shenzhen, Guangdong, supported by a workforce of 15,599 full-time employees. Its business model relies on the broad application of its pharmaceutical portfolio across multiple medical specialties, supplemented by value-added services in packaging and printing. By serving both domestic and international customers, the company leverages its full-time employee base to manage the end-to-end process from product development to global distribution.
Annual results
Reported figures, CNY · revenue up 14.4% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 31.6B | 3.4B | 10.8% | — |
| 2024 | 27.6B | 3.4B | 12.2% | — |
| 2023 | 24.7B | 2.9B | 11.5% | — |
| 2022 | 18.1B | 2.4B | 13.5% | — |
| 2021 | 15.5B | 2.1B | 13.2% | — |
Dividends per share
000999.SZ in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for China Resources Sanjiu Medical & Pharmaceutical Co Ltd are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.